Loading resource…

School of Pharmacy, UNAM
The presentation covers various aspects of hepatic impairment, including drug elimination processes, the effects of liver cirrhosis on pharmacokinetics, and the Child-Pugh classification for assessing liver function. It highlights the importance of understanding hepatic clearance and the adjustments needed for drug dosing in patients with liver disease. The document serves as a comprehensive resource for healthcare professionals dealing with pharmacotherapy in patients with hepatic impairment.
No account needed